Published in J Clin Invest on March 01, 1976
Insulin resistance in uremia. J Clin Invest (1981) 1.98
Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest (1978) 1.55
Kinetics of glucagon in man: effects of starvation. Proc Natl Acad Sci U S A (1976) 1.22
Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man. J Clin Invest (1976) 1.03
Retracted Glucagon binding and adenylate cyclase activity in liver membranes from untreated and insulin-treated diabetic rats. J Clin Invest (1978) 0.92
Pathogenesis and characterization of hyperglucagonemia in the uremic rat. J Clin Invest (1976) 0.92
Abnormal carbohydrate metabolism in chronic renal failure. The potential role of accelerated glucose production, increased gluconeogenesis, and impaired glucose disposal. J Clin Invest (1978) 0.90
Retracted Glucagon and insulin binding to liver membranes in a partially nephrectomized uremic rat model. J Clin Invest (1977) 0.89
Effects of glucagon on plasma amino acids. J Clin Invest (1984) 0.88
The role of the liver in glucagon metabolism. J Clin Invest (1977) 0.88
Glucagon deficiency and hyperaminoacidemia after total pancreatectomy. J Clin Invest (1980) 0.83
Glucagon metabolism in the rat. J Clin Invest (1978) 0.80
Effect of glucagon on protein synthesis in human rectal cancer in situ. Ann Surg (1998) 0.80
Glucagon sensitivity and clearance in type 1 diabetes: insights from in vivo and in silico experiments. Am J Physiol Endocrinol Metab (2015) 0.75
Glycaemic control in diabetic nephropathy. Br Med J (Clin Res Ed) (1984) 0.75
Effects of glucose-containing peritoneal-dialysis solutions on rates of lipogenesis in vivo in the liver, brown and white adipose tissue of chronic uraemic rats. Biochem J (1983) 0.75
Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose. Lancet (1957) 19.82
Amino acid metabolism during prolonged starvation. J Clin Invest (1969) 4.06
Amino acid metabolism in man. Annu Rev Biochem (1975) 2.88
REVIEW: THE USE OF ISOTOPIC STEROIDS FOR THE MEASUREMENT OF PRODUCTION RATES IN VIVO. J Clin Endocrinol Metab (1963) 2.42
Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man. J Clin Invest (1973) 2.04
Hyperglucagonemia in diabetic ketoacidosis. Its prevalence and significance. Am J Med (1973) 1.66
Hyperglucagonemia of renal failure. J Clin Invest (1974) 1.45
Effect of chronic renal failure and hemodialysis on carbohydrate metabolism. J Clin Invest (1966) 1.30
Portal and peripheral vein immunoreactive glucagon concentrations after arginine or glucose infusions. Diabetes (1974) 1.23
Abnormal carbohydrate metabolism in renal disease. Blood glucose unresponsiveness to hypoglycemia, epinephrine, and glucagon. Ann Intern Med (1962) 1.23
Carbohydrate metabolism in uremia: a review. Medicine (Baltimore) (1973) 1.17
Concentrations of glucagon and the insulin:glucagon ratio in the portal and peripheral circulation. Proc Soc Exp Biol Med (1974) 1.14
Carbohydrate metabolism in renal disease. Q J Med (1970) 1.11
Azotemia and glucose intolerance. Ann Intern Med (1967) 1.06
Insulin effect in uremia. J Lab Clin Med (1969) 1.06
Pancreatic alpha-cell function in trauma. JAMA (1974) 1.05
Evaluation of alpha-cell function by infusion of alanine in normal, diabetic and obese subjects. N Engl J Med (1973) 1.05
Evaluation of amino acid and protein requirements in chronic uremia. Arch Intern Med (1970) 1.02
Glucagon control of fasting glucose in man. Lancet (1974) 1.02
Lack of dialyzable insulin antagonist in uremia. Metabolism (1969) 0.99
Glucose metabolism and insulin secretion in uremic, prediabetic, and normal subjects. J Lab Clin Med (1970) 0.98
Hyperglucagonemia in uremia: reversal by renal transplantation. Ann Intern Med (1975) 0.95
Serum glucagon and insulin levels and their relationship to blood glucose values in patients with acute myocardial infarction and acute coronary insufficiency. Am J Med (1974) 0.92
Amino acid metabolism in uraemic patients. Clin Chim Acta (1971) 0.91
Apparent free amino acids in deproteinized plasma of normal and uremic persons. J Clin Invest (1957) 0.89
Renal handling of endogenous glucagon in the dog: comparison with insulin. Metabolism (1974) 0.86
Plasma amino acid levels of men fed diets differing in protein content. Some observations with valine-deficient diets. J Nutr (1966) 0.84
THE PLASMA AMINOGRAM IN KWASHIORKOR. Lancet (1963) 0.84
Plasma glucagon in nonketotic hyperosmolar coma. JAMA (1974) 0.83
The effect of dialysis on the carbohydrate intolerance of chronic renal failure. Horm Metab Res (1970) 0.83
Effect of acute uremia on various aspects of carbohydrate metabolism in dogs. Kidney Int (1973) 0.79
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J (2005) 5.40
Plasma amino acid levels and insulin secretion in obesity. N Engl J Med (1969) 4.18
Amino acid metabolism during prolonged starvation. J Clin Invest (1969) 4.06
Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med (1986) 3.90
Liver and kidney metabolism during prolonged starvation. J Clin Invest (1969) 3.47
The glucose-alanine cycle. Metabolism (1973) 3.43
Alanine: key role in gluconeogenesis. Science (1970) 3.43
A model of the kinetics of insulin in man. J Clin Invest (1974) 2.97
Amino acid balance across tissues of the forearm in postabsorptive man. Effects of insulin at two dose levels. J Clin Invest (1969) 2.94
Amino acid metabolism in man. Annu Rev Biochem (1975) 2.88
Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes. Int J Clin Pract (2010) 2.75
Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med (1998) 2.58
Psychiatric morbidity and compulsory admission among UK-born Europeans, Afro-Caribbeans and Asians in central Manchester. Br J Psychiatry (1993) 2.52
Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes (1983) 2.45
The problem of associating coagulase-negative staphylococci with disease. Ann N Y Acad Sci (1965) 2.43
Substrate turnover during prolonged exercise in man. Splanchnic and leg metabolism of glucose, free fatty acids, and amino acids. J Clin Invest (1974) 2.40
Human calcitonin in the treatment of Paget's bone disease. Lancet (1971) 2.37
Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes (1995) 2.30
Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med (1987) 2.30
Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV Med (2003) 2.30
Influence of endogenous insulin secretion on splanchnic glucose and amino acid metabolism in man. J Clin Invest (1971) 2.29
Amino acid metabolism in exercising man. J Clin Invest (1971) 2.29
Effect of protein ingestion on splanchnic and leg metabolism in normal man and in patients with diabetes mellitus. J Clin Invest (1976) 2.27
Glucose metabolism during leg exercise in man. J Clin Invest (1971) 2.27
Detection of diabetic macular edema. Ophthalmoscopy versus photography--Early Treatment Diabetic Retinopathy Study Report Number 5. The ETDRS Research Group. Ophthalmology (1989) 2.24
13C/31P NMR studies on the mechanism of insulin resistance in obesity. Diabetes (1998) 2.21
The AKT kinase is activated in multiple myeloma tumor cells. Blood (2001) 2.20
Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells. Science (1999) 2.19
Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest (1997) 2.16
Is skin preparation necessary before insulin injection? Lancet (1978) 2.15
Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus. J Clin Invest (1972) 2.11
Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science (1985) 2.10
Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J Clin Invest (1994) 2.09
Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis. Ann Intern Med (1990) 2.09
Insulin control of glucose metabolism in man: a new kinetic analysis. J Clin Invest (1975) 2.09
Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange. Proc Natl Acad Sci U S A (1978) 2.08
American Academy of Pediatrics. Committee on Adolescence. Contraception in adolescents. Pediatrics (1999) 2.06
Is alignment within 8 prism diopters of orthotropia a successful outcome for infantile esotropia surgery? Arch Ophthalmol (1996) 2.06
Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes (1982) 2.06
Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man. J Clin Invest (1973) 2.04
Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol (1998) 2.00
Insulin resistance in uremia. J Clin Invest (1981) 1.98
An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Nature (1989) 1.97
Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients. Ann Intern Med (1980) 1.96
Should baseline PSA testing be performed in men aged 40 to detect those aged 50 or less who are at risk of aggressive prostate cancer? S Afr Med J (2011) 1.95
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med (2003) 1.94
Retracted Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes. J Clin Invest (1979) 1.94
Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect Immun (2000) 1.93
Assessment of health needs and willingness to utilize health care resources of adolescents in a suburban population. J Pediatr (1983) 1.90
Cardiopulmonary resuscitation directives on admission to intensive-care unit: an international observational study. Lancet (2001) 1.90
Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes (1988) 1.89
Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med (1979) 1.88
Effect of ketone infusions on amino acid and nitrogen metabolism in man. J Clin Invest (1975) 1.87
Precipitants of brain infarction. Roles of preceding infection/inflammation and recent psychological stress. Stroke (1996) 1.86
Increased tumorigenicity of fibronectin receptor deficient Chinese hamster ovary cell variants. Cancer Res (1991) 1.86
Peroral gene therapy of lactose intolerance using an adeno-associated virus vector. Nat Med (1998) 1.79
Trial of Whooping-cough Vaccine. Br Med J (1945) 1.76
Plasma amino acid levels in diabetic ketoacidosis. Diabetes (1970) 1.76
Retracted Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding. J Clin Invest (1978) 1.73
Splanchnic glucose and amino acid metabolism in obesity. J Clin Invest (1974) 1.73
Fuel homeostasis in exercise. N Engl J Med (1975) 1.73
Ampicillin levels in sputum, serum, and saliva. Thorax (1970) 1.73
Rocuronium: high risk for anaphylaxis? Br J Anaesth (2001) 1.72
Missed opportunities for diagnosing primary HIV infection. Sex Transm Infect (2007) 1.72
The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection. AIDS (1994) 1.70
Blood volume replacement in acute anaphylactic cardiovascular collapse related to anaesthesia. Br J Anaesth (1977) 1.70
Influence of oral glucose ingestion on splanchnic glucose and gluconeogenic substrate metabolism in man. Diabetes (1975) 1.68
A syndrome of acute zinc deficiency during total parenteral alimentation in man. Ann Surg (1976) 1.62
Evidence of inter-organ amino-acid transport by blood cells in humans. Proc Natl Acad Sci U S A (1973) 1.60
A pilot qualitative analysis of the psychosocial factors which drive young people to decline chlamydia testing in the UK: implications for health promotion and screening. Int J STD AIDS (2010) 1.60
Synergistic interaction between exercise and insulin on peripheral glucose uptake. J Clin Invest (1981) 1.59
Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke (2004) 1.59
The British HIV Association/British Association for Sexual Health and HIV Position Statement on pre-exposure prophylaxis in the UK. Int J STD AIDS (2012) 1.59
Influence of maturity-onset diabetes on splanchnic glucose balance after oral glucose ingestion. Diabetes (1978) 1.58
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Immunohematologic characteristics of infection-associated cerebral infarction. Stroke (1991) 1.55
Effect of starvation on the turnover and metabolic response to leucine. J Clin Invest (1978) 1.54
Depression in chronic dialysis patients: assessment and treatment. Nephrol Dial Transplant (2000) 1.52
Transient and permanent resolution of ischemic lesions on diffusion-weighted imaging after brief periods of focal ischemia in rats : correlation with histopathology. Stroke (2000) 1.52
Atherosclerosis: current concepts on pathogenesis and interventional therapies. Ann Neurol (1989) 1.51
Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr (1989) 1.51
Somatostatin decreases diarrhea in patients with the short-bowel syndrome. J Clin Gastroenterol (1982) 1.50
Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): report of 2 cases and review of the literature. Ann Neurol (1978) 1.50
Nanometal surface energy transfer in optical rulers, breaking the FRET barrier. J Am Chem Soc (2005) 1.48
Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin. J Clin Invest (1989) 1.47